Allgens Medical Technology Co., Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Allgens Medical Technology Co., Ltd.

Why is Allgens Medical Technology Co., Ltd. ?

Poor Management Efficiency with a low ROCE of 16.07%

The company has been able to generate a Return on Capital Employed (avg) of 16.07% signifying low profitability per unit of total capital (equity and debt)

Poor long term growth as Net Sales has grown by an annual rate of -3.33% and Operating profit at -166.13% over the last 5 years

The company has declared Negative results for the last 8 consecutive quarters

NET PROFIT(HY) At CNY -24.11 MM has Grown at -3,995.1%
OPERATING CASH FLOW(Y) Lowest at CNY 23.06 MM
ROCE(HY) Lowest at -1.32%

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -0.74%, its profits have fallen by -334.4%

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -0.74% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Allgens Medical Technology Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Allgens Medical Technology Co., Ltd.

-100.0%

1.36

47.85%

China Shanghai Composite

14.03%

0.86

14.45%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-3.33%

EBIT Growth (5y)

-166.13%

EBIT to Interest (avg)

24.38

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.71

Sales to Capital Employed (avg)

0.15

Tax Ratio

53.78%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

16.07%

ROE (avg)

4.11%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.92

EV to EBIT

-67.16

EV to EBITDA

-1160.94

EV to Capital Employed

4.15

EV to Sales

8.59

PEG Ratio

Dividend Yield

ROCE (Latest)

-6.19%

ROE (Latest)

-1.53%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company

NET PROFIT(Q)

At CNY -2.55 MM has Grown at 79.12%

-25What is not working for the Company

NET PROFIT(HY)

At CNY -24.11 MM has Grown at -3,995.1%

OPERATING CASH FLOW(Y)

Lowest at CNY 23.06 MM

ROCE(HY)

Lowest at -1.32%

DEBT-EQUITY RATIO (HY)

Highest at -70.16 %

RAW MATERIAL COST(Y)

Grown by 14.1% (YoY

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.35%

NET SALES(Q)

Lowest at CNY 41.35 MM

Here's what is working for Allgens Medical Technology Co., Ltd.

Net Profit

At CNY -2.55 MM has Grown at 79.12%

over average net sales of the previous four periods of CNY -12.22 MM

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

Here's what is not working for Allgens Medical Technology Co., Ltd.

Net Sales

At CNY 41.35 MM has Fallen at -18.31%

over average net sales of the previous four periods of CNY 50.61 MM

MOJO Watch

Near term sales trend is extremely negative

Net Sales (CNY MM)

Operating Cash Flow

Lowest at CNY 23.06 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Debt-Equity Ratio

Highest at -70.16 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Net Sales

Lowest at CNY 41.35 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Inventory Turnover Ratio

Lowest at 1.35%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Raw Material Cost

Grown by 14.1% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales